Form 4: Neurocrine Biosciences Director Christine Poon Reports Stock Transactions
SEC Form 4 Filing
Director Christine Poon reports acquisition and disposal of Neurocrine Biosciences stock and restricted stock units.
Summary
- On May 22, 2025, Christine Poon, a director of Neurocrine Biosciences Inc., reported transactions involving the company's stock.
- Poon acquired 1,435 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.
- Poon also disposed of 1,435 shares of common stock.
- Following these transactions, Poon directly owns 3,318 derivative securities and 1,435 shares of common stock.
- Additionally, Poon was granted 3,318 restricted stock units on May 21, 2025, which will vest on May 21, 2026.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, in this case a director, trades in their company's stock. It provides transparency to the market regarding the transactions of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of earliest transaction and grant date of 3,318 RSUs. |
| 05/22/2025 | Date of reported stock transactions (acquisition and disposal) and signature date. |
| 05/21/2026 | Vesting date for 3,318 RSUs. |
Keywords
Neurocrine Biosciences, Director, Christine Poon, Stock, RSU, Restricted Stock Unit, NBIX, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.